Dermatology Research: Our Current Activities

Dedicated to Conducting the Highest Quality of Clinical Research

We are dedicated to improving the quality of life for those suffering from skin disorders and diseases.  If you are interested in learning more about our research program and current study activities, please contact our clinic at (206) 267-2100, or email us at info@DASeattle.com.

Resource Websites

Brief Description Website
Nonprofit organization that is the voice for people affected by psoriasis and psoriatic arthritis www.Psoriasis.org
Use this site to find a wealth of information about clinical research www.CenterWatch.com
Provides information about federally and privately supported clinical research in human volunteers www.ClinicalTrials.gov

Psoriasis Research & Treatment

Trademark / Brand Website
Enbrel ® www.enbrel.com
Amevive ® www.amevive.com
Remicade ® www.remicade.com
Stelera ® www.stelera.com

Current Study Activities

Dr. Goffe has served as principal investigators for numerous clinical trials over the years. Our facility is continually active with different types of research studies. Below is a list of the studies that we are currently enrolling for:

If you would like to learn more about participation in one of these studies or future investigational studies, please contact us at (206) 267-2100 to speak with our research staff about enrollment, or contact us for more information.

If you feel you have interest in participating in any of the research trials, please call to speak with our research staff about enrollment.

Non-Therapeutic Interventional Phase 4 Study

 Criteria  Diagnosis  Age
Prevalence of Psoriatic Arthritis in Adults with Psoriasis Psoriasis 18 years of age or older

Topical Drug Studies

 Drug/Criteria  Diagnosis  Age
Taclonex Ointment; phase II Psoriasis on trunk and limbs (5-30% BSA) Pediatrics 12 17 y/o

Registry Studies (Database only no drug)

 Criteria  Diagnosis  Age
Previous Amevieve use Psoriasis 18 years of age or older
Previous Tacrolimus ointment use for 6 weeks minimum before age 16 Atopic Dermatitis Any age
Newly initiated to Humira (within 4 weeks of pts 1st dose of Humira Psoriasis 18 years of age or older
Eligible for or current use of the following; topical, PT, Immunemodulators, steroid therapy, biologics Psoriasis 18 years of age or older

Upcoming Drug Studies

Drug/Criteria  Diagnosis  Age
 Topical biologic, phase IIb
Moderate, severe and very severe plaque psoriasis
less than 20% of BSA at 1st visit		 Plaque Psoriasis 18 years of age or older
Oral biologic, phase III
Diagnosis of Psoriasis for at least 12 mos before enrolling in study; 10% BSA		 Moderate to Severe Chronic plaque Psoriasis 18 years of age or older
Oral biologic, phase IIa
Diagnosis of stable plaque type psoriasis for 6 mos 10% BSA		 Moderate to Severe Chronic plaque Psoriasis 18 years of age or older

Laser Studies

 Criteria  Diagnosis  Age
Lab confirmed diagnosis of onychomycosis Onychomycosis 18 years of age or older
2-3 weeks post suture removal Surgical scars 18 years of age or older
Skin types I-IV Rosacea 18 years of age or older
Skin Types V-VI Hyper-pigmentation 18 years of age or older
Skin types I-IV with acne scarring and/or wrinkles Skin Texture 18 years of age or older

 

^ Top